CBD for Epilepsy in the UK

 

Introduction

Epilepsy, a neurological disorder characterised by recurrent seizures, affects millions of people worldwide, including a substantial number of individuals in the United Kingdom. For decades, medical researchers have explored various treatment options, and one promising avenue that has gained significant attention is the use of CBD (cannabidiol) for managing epilepsy. In this blog, we will delve into the successful studies surrounding CBD for epilepsy in the UK, along with existing medications that utilise CBD as a potential therapeutic agent.

Understanding CBD and its Mechanism of Action

CBD, one of the many cannabinoids found in the cannabis plant, is non-psychoactive, meaning it does not induce a "high" sensation commonly associated with THC (tetrahydrocannabinol). Instead, CBD interacts with the body's endocannabinoid system, which plays a vital role in regulating various physiological processes, including pain perception, immune response, and neuronal activity.

The Link Between CBD and Epilepsy: Successful Studies

Over the past decade, numerous scientific studies have explored the potential of CBD as an adjunct therapy for epilepsy. Particularly, a groundbreaking clinical trial published in the New England Journal of Medicine demonstrated compelling evidence. The study focused on patients with Dravet syndrome and Lennox-Gastaut syndrome, two severe forms of childhood-onset epilepsy known for their resistance to traditional anti-seizure medications.

The trial revealed that CBD significantly reduced the frequency and severity of seizures in a substantial number of participants. As a result, the United States Food and Drug Administration (FDA) approved Epidiolex, a pharmaceutical-grade CBD medication, for the treatment of both Dravet syndrome and Lennox-Gastaut syndrome. Remarkably Epidiolex whilst certified medical grade standard, is at the very root a CBD Isolate oil!

CBD Medications Available in the UK

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of Epidyolex (a formulation of CBD) in 2019 for patients over the age of two suffering from these severe forms of epilepsy. This approval marked a significant milestone in providing an alternative treatment option for those who do not respond to conventional anti-epileptic drugs.

Epidyolex contains highly purified CBD and is carefully manufactured to ensure consistency in dosing and quality. Its approval in the UK was supported by robust clinical data, further solidifying the credibility of CBD as a viable option for epilepsy management.

CBD in Combination with Traditional Epilepsy Medications

Beyond standalone CBD medications, there is growing evidence that suggests CBD may enhance the effectiveness of traditional anti-epileptic drugs when used in combination. Researchers have explored the concept of "cannabinoid-antiepileptic drug synergy," wherein CBD enhances the therapeutic effects of existing medications and potentially reduces their adverse side effects.

It is essential to highlight that while CBD shows great promise, it is not a cure for epilepsy. Instead, it serves as a valuable addition to the existing treatment arsenal, providing hope for patients who have previously experienced limited success with other medications. Our Scientific Advisor Dr Eric LE Fevre has written an interesting piece on a wider variety of clinical studies and supporting evidence for CBD and future healthcare.

The Importance of Professional Guidance

As with any medical treatment, it is crucial for individuals considering CBD for epilepsy management to seek professional medical advice. A qualified neurologist or epilepsy specialist can assess the individual's specific condition and medical history to determine whether CBD is a suitable option and, if so, what the appropriate dosage should be. This absolutely goes for anyone thinking of purchasing from us for this reason. Please do seek medical advice first.

Conclusion

CBD's potential as a treatment for epilepsy has garnered significant attention in recent years, backed by successful studies and the development of dedicated medications like Epidyolex. While CBD for epilepsy in the UK shows promising results, it is vital to approach its use with caution, under the guidance of healthcare professionals. As research continues to unfold, there is hope for more effective management of epilepsy, offering a brighter future for those living with this challenging neurological condition.

At Associated CBD The No.1 CBD marketplace we focus on quality, affordability and range of products. Please check us out.

Thanks for reading, good luck and reach out with questions directly via our live chat or at our linkedin